Skip to main content
Top

Acta Diabetologica

Issue 5/2018

Content (13 Articles)

Review Article

Advances in micro- and nanotechnologies for the GLP-1-based therapy and imaging of pancreatic beta-cells

Faruk H. Moonschi, Corey B. Hughes, George M. Mussman, John L. Fowlkes, Chris I. Richards, Iuliana Popescu

Original Article

Identification of megakaryocytes as a target of advanced glycation end products in diabetic complications in bone marrow

Benfang Wang, Jianjiang Yu, Ting Wang, Ying Shen, Dandan Lin, Xin Xu, Yiqiang Wang

Original Article

Association between IgH enhancer hs1.2 and type 1 diabetes

Rossella Cianci, Pietro D’Addabbo, Giovanni Gambassi, Serena Lolli, Eliseo Serone, Alessandro Rizzi, Dario Pitocco, Franco Pandolfi, Domenico Frezza

Original Article

Comparative evaluation of pharmacokinetics and pharmacodynamics of insulin glargine (Glaritus®) and Lantus® in healthy subjects: a double-blind, randomized clamp study

Ashima Bhatia, Shraddha Tawade, Mushtaque Mastim, Eliford Ngaimisi Kitabi, Mathangi Gopalakrishnan, Manish Shah, Sridhar Yeshamaina, Joga Gobburu, Maharaj Sahib, Dipak Thakur, K. M. Prasanna Kumar

Original Article

The risk of type 2 diabetes mellitus according to the categories of body mass index: the Korean Genome and Epidemiology Study (KoGES)

Ju Young Jung, Sung Keun Park, Chang Mo Oh, Jae-Hong Ryoo, Joong-Myung Choi, Young Joon Choi

Open Access Original Article

Work-loss years among people diagnosed with diabetes: a reappraisal from a life course perspective

Mikaela B. von Bonsdorff, Monika E. von Bonsdorff, Maija Haanpää, Minna Salonen, Tuija M. Mikkola, Hannu Kautiainen, Johan G. Eriksson

Original Article

Heterogeneity of gestational diabetes (GDM) and long-term risk of diabetes and metabolic syndrome: findings from the RADIEL study follow-up

Emilia Huvinen, Johan G. Eriksson, Saila B. Koivusalo, Nora Grotenfelt, Aila Tiitinen, Beata Stach-Lempinen, Kristiina Rönö

Original Article

SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials

Robert Puckrin, Marie-Philippe Saltiel, Pauline Reynier, Laurent Azoulay, Oriana H. Y. Yu, Kristian B. Filion

Short Communication

Soluble programmed death-1 ligand 1(sPD-L1) is significantly reduced in the serum of type 1 diabetes patients

Xiaohong Chen, Heming Guo, Sicheng Li, Cuiping Liu, Sisi Ding, Yun Huang, Chen Fang, Ji Hu

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.